Equibles does not estimate personal net worth.
Imunon, Inc. reported in an 8-K filed February 5, 2026 that Khursheed Anwer retired as Executive Vice President and Chief Scientific Officer, effective February 20, 2026. The proxy statement of Imunon, Inc. reports total compensation of $741,680 for Khursheed Anwer in fiscal 2024, including a base salary of $385,610. Disclosed compensation is on record for 7 fiscal years. Khursheed Anwer has spoken on 4 earnings calls across 1 company, most recently for Imunon, Inc. on November 13, 2025. The companies whose calls Khursheed Anwer spoke on are classified in the Healthcare sector.
“On February 2, 2026, Khursheed Anwer informed Imunon, Inc. (the "Company") of his intent to retire as Executive Vice President and Chief Scientific Officer from the Company, and Dr. Anwer's employment with the Company will end, effective February 20, 2026 (the "Retirement Date").”
“The unformulated plasmid, which is administered into the peritoneal cavity, typically clears, I would say, within 24 hours and may last a little longer if it is formulated with a delivery system such as that in IMNN-001, where the nanocomplexes have a protective effect on the DNA.”
“No, I mean, I think you've covered pretty much Corinne but I just wanted to start with Emily's last part of the question, which you just kind of addressed that potential mechanisms.”
“As you know, the new variants are emerging; they are the BQ.1, BQ1.1, and XBB on the horizon. So clearly, we will be getting some feedback from the FDA on what makes the most sense in terms of combination.”
“Our proof-of-concept objectives are to demonstrate that from a single DNA-based plasmid, you can express antigens for two different strains of a virus. We've been modeling SARS-CoV-2 as a benchmark because there are commercial products out there for competitive purposes.”
Proxy statement
Start not stated–2026-02-20
IMNN
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Imunon, Inc. (IMNN) | Executive VP & CSO | $385,610 | $741,680 |
| 2023 | Imunon, Inc. (IMNN) | Executive VP & CSO | $412,760 | $680,159 |
| 2022 | Imunon, Inc. (IMNN) | Executive VP & CSO | $382,629 | $678,658 |
| 2021 | Imunon, Inc. (IMNN) | Executive VP & CSO | $362,878 | $1,020,478 |
| 2020 | Imunon, Inc. (IMNN) | Executive VP & CSO | $335,852 | $643,848 |
| 2019 | Imunon, Inc. (IMNN) | Executive VP & CSO | $325,442 | $650,698 |
| 2018 | Imunon, Inc. (IMNN) | Executive Vice President & CSO | $316 | $666,642 |
